ATE529441T1 - Expression von proteinen in e.coli - Google Patents

Expression von proteinen in e.coli

Info

Publication number
ATE529441T1
ATE529441T1 AT06778399T AT06778399T ATE529441T1 AT E529441 T1 ATE529441 T1 AT E529441T1 AT 06778399 T AT06778399 T AT 06778399T AT 06778399 T AT06778399 T AT 06778399T AT E529441 T1 ATE529441 T1 AT E529441T1
Authority
AT
Austria
Prior art keywords
coli
proteins
expression
dna
sequence
Prior art date
Application number
AT06778399T
Other languages
English (en)
Inventor
Helle Woeldike
Christine Schiydt
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE529441T1 publication Critical patent/ATE529441T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT06778399T 2005-08-30 2006-08-30 Expression von proteinen in e.coli ATE529441T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05107918 2005-08-30
PCT/EP2006/065817 WO2007025987A1 (en) 2005-08-30 2006-08-30 Expression of proteins in e.coli

Publications (1)

Publication Number Publication Date
ATE529441T1 true ATE529441T1 (de) 2011-11-15

Family

ID=37402515

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06778399T ATE529441T1 (de) 2005-08-30 2006-08-30 Expression von proteinen in e.coli

Country Status (5)

Country Link
US (1) US7858747B2 (de)
EP (1) EP1924601B1 (de)
AT (1) ATE529441T1 (de)
ES (1) ES2375573T3 (de)
WO (1) WO2007025987A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE529441T1 (de) 2005-08-30 2011-11-15 Novo Nordisk As Expression von proteinen in e.coli
US20100041153A1 (en) * 2007-03-01 2010-02-18 Novo Nordisk Healthcare Ag Expression of Proteins in E. Coli
US10273474B2 (en) 2012-03-30 2019-04-30 Washington University Methods for modulating Tau expression for reducing seizure and modifying a neurodegenerative syndrome
RU2745324C2 (ru) 2013-03-14 2021-03-23 Ионис Фармасьютикалз, Инк. Композиции и способы модулирования экспрессии tau
TWI772856B (zh) 2013-07-19 2022-08-01 美商百健Ｍａ公司 用於調節τ蛋白表現之組合物
EP3312278B1 (de) * 2015-06-16 2024-12-04 National University Corporation Nagoya University Proteinexpressionsverfahren
JP6889769B2 (ja) 2016-07-18 2021-06-18 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 核酸配列決定の非対称な鋳型および非対称な方法
CN109312391B (zh) 2016-07-18 2022-06-03 豪夫迈·罗氏有限公司 生成用于单分子测序的单链环状dna文库的方法
JPWO2018025826A1 (ja) * 2016-08-03 2019-05-30 国立大学法人名古屋大学 標識タンパク質を融合した抗体
JOP20190065A1 (ar) 2016-09-29 2019-03-28 Ionis Pharmaceuticals Inc مركبات وطرق لتقليل التعبير عن tau
CN111315895A (zh) 2017-09-14 2020-06-19 豪夫迈·罗氏有限公司 用于产生环状单链dna文库的新型方法
EP3682027B1 (de) 2017-09-15 2025-02-26 F. Hoffmann-La Roche AG Strategie zur hybridisierungverlängerungsligation zur erzeugung von bibliotheken aus zirkulärer einzelsträngiger dna
EP3692166A1 (de) 2017-10-06 2020-08-12 H. Hoffnabb-La Roche Ag Zirkularisierungsverfahren zur vorbereitung einer einzelmolekülsequenzierungsprobe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340522C (en) * 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
FR2756827B1 (fr) * 1996-12-05 1999-01-29 Pasteur Sanofi Diagnostics Composes synthetiques biepitopiques utilisables comme etalons dans les dosages biologiques de la troponine i
EP1436409A2 (de) * 2001-09-07 2004-07-14 Massachusetts Institute Of Technology Lanthanidbindungstags
AU2003279240A1 (en) 2002-06-21 2004-01-06 Genetix Pharmaceuticals, Inc. Methods for purifying viral particles for gene therapy
JP4664684B2 (ja) 2002-12-13 2011-04-06 ザイモジェネティクス， インコーポレイテッド 原核生物宿主におけるｉｌ−２１の生産
WO2006062685A2 (en) 2004-11-11 2006-06-15 Affymax, Inc. Novel peptides that bind to the erythropoietin receptor
ATE529441T1 (de) 2005-08-30 2011-11-15 Novo Nordisk As Expression von proteinen in e.coli

Also Published As

Publication number Publication date
US20090035821A1 (en) 2009-02-05
US7858747B2 (en) 2010-12-28
EP1924601A1 (de) 2008-05-28
WO2007025987A1 (en) 2007-03-08
ES2375573T3 (es) 2012-03-02
EP1924601B1 (de) 2011-10-19

Similar Documents

Publication Publication Date Title
ATE529441T1 (de) Expression von proteinen in e.coli
DK1601776T3 (da) Ekspressionsvektorer omfattende mCmV-IE2-promotoren
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
ATE529442T1 (de) Verbesserte humane interferon-moleküle und ihre verwendungen
ATE462006T1 (de) Isoform des vegfs
AR049177A1 (es) Polipeptidos y conjugados de interferon-alfa
ATE473238T1 (de) Tuberkulose vaccine mit verbesserter effizienz
AR067980A1 (es) Peptidos de cdh3 y agentes que los comprenden
CY1114526T1 (el) Κατασταλτικες πρωτεϊνες μιας πρωτεασης (protease) και χρησεις αυτων
ATE443076T1 (de) Von protease typ ii spaltbares peptid
DE602004027767D1 (de) Promotoren zur Expression in modifiziertem Vaccinia Virus Ankara
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
DK1339853T3 (da) Isolerede luciferaser og deres anvendelse
ATE449107T1 (de) Aus fisch gewonnene peptide und nukleinsäuren der cathelicidin familie und deren verwendung
BR0010222A (pt) Vetores de expressão viral
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
DK1383796T3 (da) Neurovirulent stamme af viruset West Nile og anvendelser heraf
DE50304603D1 (de) Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze
NO20085201L (no) Rekombinante novirhabdoviruser og deres anvendelse
FI20030851A7 (fi) CARD-geenistä ylävirtaan olevia sekvenssejä, niitä sisältäviä vektoreita ja niiden käyttöjä
SE0101519D0 (sv) Nucleic ACID
DK1196607T3 (da) Antibakterielt chlamysin B-protein, gen kodende derfor samt ekspressionssystem
KR20040053279A (ko) 스트레스 저항성 및 내성 단백질을 코딩하는 유전자
FR2866025B1 (fr) Utilisation des proteines et des peptides codes par le genome d'une nouvelle souche de coronavirus associe au sras
DE60330140D1 (de) Gen-silencing-vektor und diesen verwendendes gen-silencing-verfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties